This PPT gives the students the basic physiology of the Thyroid gland. It is the only Endocrine gland that can be palpable with your hands. Very useful to M.B.B.S; B.D.S as well as PG students.
Objectives
Formation of Thyroid hormones
Peripheral Conversion
Hormonal transport
Actions of Thyroid hormones
Regulation of Thyroid hormones
Thyroid
Essential for:
Development & Regulation
of Metabolism
Constant supply is essential
for
Normal growth
Brain development
Maintenance of
metabolism
Functional activity of
many organs
Follicles: the Functional Units of the
Thyroid Gland
Follicles Are the Sites
Where Key Thyroid
Elements Function:
• Thyroglobulin (Tg)
• Tyrosine
• Iodine
• Thyroxine (T4)
• Triiodotyrosine (T3)
Iodine
Necessary – synthesis – thyroid
hormones.
Iodine → iodide & absorbed
SI – stomach & jejunum
90-95% - absorbed iodide taken up by
thyroid
Iodine Sources
Available through certain foods (eg,
seafood, bread, dairy products, eggs),
iodized salt, or dietary supplements,
drinking water as a trace mineral
The recommended minimum intake is
0.1mg/day
Biosynthesis of T4 and T3
1. Iodide Trapping
Dietary iodine (I) ingestion
Active transport and uptake of iodide
(I-
) by thyroid gland – First step
Dehalogenase enzyme
Thiocyanates + Perchlorates ≠ block
Biosynthesis of T4 and T3
2. Oxidation
Iodide → Inorganic iodine
Thyroperoxidase (TPO) enzyme
Thioamides ≠ block
Sulphonamides / PAS / Carbimazole / PT
Biosynthesis of T4 and T3
3. Binding - Iodination
Binding with tyrosine
Formation of iodotyrosines
Thyroperoxidase (TPO) enzyme
Iodine + tyrosine ═ MIT & DIT
Thiourea groups ≠ block
Carbimazole
Biosynthesis of T4 and T3
4. Coupling
2 molecule – DIT ═ T4
1 molecule ═ T3
Dehalogenase enzyme
Thiourea groups ≠ block
Carbimazole
Biosynthesis of T4 and T3
5. Proteolysis / Hydrolysis
Hormones + globulin ═ colloid ( Tg )
Stored in thyroid gland
Proteolysis of Tg with release of T4and
T3into the circulation - required
Plasma iodide enters
through the sodium iodide
symporter (NIS).
•Thyroglobulin (Tg), a
large glycoprotein, is
synthesized within the
thyroid cell.
•Thyroid peroxidase (TPO)
sits on the lumenal
membrane. It iodinates
specific tyrosines in Tg,
creating mono-and di-
iodotyrosines.
•The iodotyrosines
combine to form T3 and
T4 within the Tg protein
In response to TSH,
pseudopodia form and
endocytose colloid.
•In the cell, colloid
droplets fuse with
lysosomes and thyroid
hormone is cleaved
enzymatically from Tg.
•T4 and T3 are released
into the circulation.
•TSH stimulates
iodide trapping, as
well as thyroid
hormone synthesis
and secretion
Active Transport and I-
Uptake by the
Thyroid
Dietary iodine reaches the
circulation as iodide anion (I-
)
The thyroid gland transports I-
to the
sites of hormone synthesis
I-
accumulation in the thyroid is an
active transport process that is
stimulated by TSH
NIS is a membrane protein that
mediates active iodide uptake by the
thyroid
ION TRANSPORT BY THE
THYROID FOLLICULAR CELL
I-
I- organification
Propylthiouracil (PTU)
blocks iodination of
thyroglobulin
COLLOID
BLOOD
NaI symporter (NIS)
Thyroid peroxidase (TPO)
ClO4
-
, SCN-
Proteolysis of Tg With Release of
T4 and T3
T4 and T3 are synthesized and stored within the Tg
molecule
Proteolysis is an essential step for releasing the
hormones
To liberate T4and T3, Tg is resorbed into the follicular
cells in the form of colloid droplets, which fuse with
lysosomes to form phagolysosomes
Tg is then hydrolyzed to T4and T3, which are then
secreted into the circulation
Production of T4 and T3
T4 is the primary secretory product of the
thyroid gland, which is the only source of T4
The thyroid secretes approximately 70-90 µg of
T4per day
T3 is derived from 2 processes
The total daily production rate of T3is about 15-30 µg
About 80% of circulating T3comesfrom deiodination
of T4 in peripheral tissues
About 20% comes from direct thyroid secretion
Sites of T4 Conversion
The liver is the major extrathyroidal T4
conversion site for production of T3
Some T4to T3 conversion also occurs in the
kidneys / heart / muscle and other tissues
Peripheral Conversion - process
Although T4 is the principal hormone from
Thyroid, T3 is the main hormone for regulation of
metabolism
T3 is produced by de-iodination of T4, by the
enzymes T4 -5’De-iodinase Type I & Type II
Type I T4 -5’De-iodinase is found in the Liver &
Kidneys. It is responsible for the production of ⅔
of the total T3 in the body
Type II T4 -5’De-iodinase is responsible for most
of the T3 found in the Pituitary, Brain & Brown
Fat
T3 either enters the cell or locally produced,
which is transported into the nucleus
Type III – which converts T4 → rt3 which is
biologically inactive
THYROID HORMONE
DEIODINASES
Three deiodinases (D1, D2 & D3) catalyze
the generation and/disposal of bioactive
thyroid hormone.
D1 & D2 “bioactivate” thyroid hormone by
removing a single “outer-ring” iodine atom.
D3 “inactivates” thyroid hormone by
removing a single “inner-ring”iodine atom.
All family members contain the novel
amino acid selenocysteine (SeC) in their
catalytic center.
Thyroxine (T4 )
3,5,3’,5’ tetraiodo-L-thyronine
THYROID HORMONES
•Derived entirely
from the thyroid
gland
•Is a pro-hormone
THYROID HORMONES
*Is the biologically
active thyroid
hormone
*•20% of plasma T3
comes from
thyroidal secretion
•80% comes from
T4 5’-deiodination in
peripheral organs
T3 & T4
Iodinated aminoacids
With in thyroid, integral part of TG, in which they are
synthesized & stored
In plasma, circulate as free amino acids in equilibrium
with THBP
Free forms:
Penetrate cells-induce & stimulate Oxygen
consumption,
Body heat,
Metabolism of CHO/Fat/Protein
Stimulates feedback mechanisms with Pituitary
T4 Disposition
Normal disposition of T4
About 41% is converted to T3
38% is converted to reverse T3 (rT3), which is
metabolically inactive
21% is metabolized via other pathways, such as
conjugation in the liver and excretion in the bile
Normal circulating concentrations
T4 4.5-11 µg/dL
T3 60-180 ng/dL (~100-fold less than T4)
Carriers for Circulating Thyroid
Hormones
More than 99% of circulating T4 and T3 is bound
to plasma carrier proteins
Thyroxine-binding globulin (TBG), binds about 75%
Transthyretin (TTR), also called thyroxine-binding
prealbumin (TBPA), binds about 10%-15%
Albumin binds about 7%
High-density lipoproteins (HDL), binds about 3%
Carrier proteins can be affected by physiologic
changes, drugs, and disease
Free Hormone Concept
Only unbound (free) hormone has metabolic
activity and physiologic effects
Free hormone is a tiny percentage of total hormone in
plasma (about 0.03% T4; 0.3% T3)
Total hormone concentration
Normally is kept proportional to the concentration of
carrier proteins
Is kept appropriate to maintain a constant free
hormone level
Thyro-Globulin
It is a dimeric Glyco-Protein
M.wt: 660000
Contains about 120 Tyrosyl units
30% of Tyrosyl will undergo iodination
After the synthesis of the Hormones and its
intracellular transport, exophytic residues
discharge their contents in the Folliclle
TG accumulates in the lumen
Colloid, which fills the Follicular lumen is
almost exclusively composed of Iodinated TG
Thyroid Physiology
Hormone Binding proteins are the principal
factors influenzing total hormone
concentration, which is normally maintained
at a level appropriate for the concentration of
carrier proteins, to maintain a constant free
hormone level
Various factors may cause changes in the
concentrations of TBG & changes in TBG level
may alter the total hormone concentration,
irrespective of the metabolic status or free
hormone level
TBG estimation is a more accurate indicator
of the Thyroid Hormone dependant
metabolic state
Changes in TBG Concentration Determine Binding
and Influence T4 and T3 Levels
Increased TBG
Total serum T4 and T3 levels increase
Free T4 (FT4), and free T3 (FT3) concentrations remain
unchanged
Decreased TBG
Total serum T4 and T3 levels decrease
FT4 and FT3 levels remain unchanged
Drugs and Conditions that Increase Serum T4 and
T3 Levels by Increasing TBG
Drugs that increase TBG
Oral contraceptives and
other sources of estrogen
Methadone
Clofibrate
5-Fluorouracil
Heroin
Tamoxifen
Conditions that increase
TBG
Pregnancy
Infectious/chronic active
hepatitis
HIV infection
Biliary cirrhosis
Acute intermittent porphyria
Genetic factors
Drugs and Conditions that Decrease Serum T4 and T3 by
Decreasing TBG Levels or Binding of Hormone to TBG
Drugs that decrease serum
T4and T3
Glucocorticoids
Androgens
L-Asparaginase
Salicylates
Mefenamic acid
Antiseizure medications, eg,
phenytoin, carbama-zepine
Furosemide
Conditions that decrease
serum T4and T3
Genetic factors
Acute and chronic illness
ACTIONS
BMR due to O2, Heat, Temp & Heat
intolerance. Optimum level is necessary for
balanced growth & maturation
Stimulates Lipogenesis & Lipolysis,
Lowers serum Cholesterol by enhancing
Excretion thro’ Faeces
Conversion to Bile Acids
Catecholamine effect
Brain / retina / lungs / spleen & testes are
unaffected by thyroid hormones
ACTIONS
Site Actions Outcomings
Brain Effects on activity &
mood
Hyperactivity & Mood
changes
Pituitary ↓TSH release ↓TSH level
Heart Rate; changes in
proteins
Tachycardia,
Arrhythmia, Failure
Liver LDL Receptors,
Cholesterol
synthesis,
Cholesterol excretion
& conversion to Bile
acids
↓Cholesterol
Muscle Changes in Protein Myopathy
Bone Osteoblastic & 2º
Osteoclastic activity
Osteoporosis
ACTION OF THYROID HORMONES
Parameter/ organ system
Action
Developmental Essential for normal neural and skeletal development
Calorigenesis Oxygen consumption
Basal Metabolic Rate
Intermediary Metabolism Protein Synthesis
Synthesis/ Degradation of cholesterol
Lipolysis
Glycogenolysis
Cardiovascular Heart rate and myocardial contractility
Sympathetic Nervous System Sensitivity to catecholamines
Catecholamine receptors in cardiac muscle
Amplification of catecholamine effects at postreceptor site
Endocrine Steroid hormone release
Hematopoietic Erythropoiesis
2,3 DPG production
Maintain hypoxic and hypercapnic drives
Musculo skeletal Bone turnover
Urinary hydroxy proline excretion
Increased rate of muscle relaxation
REGULATION OF THYROID HORMONE
SECRETION
Classic feed back loop that involves pituitary and
hypothalamus
Intrinsic thyroid autoregulatory process
FEEDBACK REGULATION
THE HYPOTHALAMIC-PITUITARY-THYROID AXIS
Hormones derived from the pituitary that regulate the
synthesis and/or secretion of other hormones are known as
trophic hormones.
Key players for the thyroid include:
TRH - Thyrophin Releasing Hormone
TSH - Thyroid Stimulating Hormone
T4/T3 - Thyroid hormones
TSH
TSH (Thyroid Stimulating Hormone or Thyrotrophin)
Normal Level = 0.5 to 4.5 μUnits/ML
Normal daily production & degradation is 40 to 150 μUnits
Circardian rhythm-raise 2 hours after sleep, peak from 2 to 4
AM
Initial effect of TSH is in Iodide transport
Glycoprotein
Like LH / FSH / HCG, TSH also has α & β subunits
α subunits of all the said hormones are identical
β subunits of each are responsible for biological &
immunological specificities
TSH is required for normal production & secretion of T3 & T4
Mostly influezed by tonic stimulation by TRH and feedback
inhibition by T3 & T4
T3 regulates the transcription of the GENES for both the
subunits of TSH
Effects of TSH
Iodine binding to TG
coupling of MIT & DIT
Activation of Exocytosis
Transfer of proteins into the follicles
Secretion of T3 & T4
Major factor in the growth of thyroid
Iodine & Drugs blocking the binding of Iodine to TG cause↓
TSH & diffuse enlargement of Thyroid
When TSH is low or absent (Hypophysectomy, inactive TSH) the
Thyroid gland in size↓
Prolonged TSH administration will the ↑ weight of the Thyroid
Gland
Chronic TSH leads to: proliferation of capillaries & fibroblasts
rather than Follicles
TSH binds to specific cell surface receptors that
stimulate adenylate cyclase to produce cAMP.
TSH increases metabolic activity that is required to
synthesize Thyroglobulin (Tg) and generate peroxide.
TSH stimulates both I-
uptake and iodination of
tyrosine resides on Tg.
TSH REGULATION OF
THYROID FUNCTION
TRH
Tripeptide- (pyroglutamyl-histidyl-proline amide)
First Hypothalamic hormone isolated
Produced at Supra-Optic & Para-Ventricular Nuclei
Passes thro’ their axons to median eminence and
stored
Reach the Pituitary via hypophyseal portal vessels &
binds to receptor sites
Increases the synthesis & secretion of TSH
Increases the synthesis & secretion of Prolactin
Tonic stimulation of TSH producing cells
Auto-Regulation
In Humans, the Wolff-Chaikoff’s block(acute
block of Iodide binding) is induced by
elevated plasma iodide level to ≥ 25 μGm%
Aftert the critical level of iodide, there is a
progressive inhibition of iodide binding to
tyrosyl residues in TG
Iodide adminisration leads to:
↓Iodine containing compounds from thyroid
↓ serum T3 & T4
↓in Hypervascularity Seen in
↓in Hyperplasia Hyperthyroidism
May induce Hyperthyroidism
May cause Nodularity in Goitres
WOLFF CHAIKOFF’S EFFECT
TSH independent manner by availability &
glandular content of iodide
Iodide depletion enhances iodide transport &
stimulate hormone synthesis
In the presence of excess iodide, iodide causes
suppression of both transport & hormone
synthesis
CALCITONIN
Secreted By: Parafollicular cells of Thyroid
gland
Regulation: Negative feedback mechanism
High calcium levels in blood stimulated
secretion & vice versa
Action: Decrease blood level of ionic Ca2+ &
PO4 by inhibiting bone reabsorption by
osteoclasts and uptake of Ca & PO4 in bone
matrix.
ANTI THYROID COMPOUNDS
PROCESS
AFFECTED
EXAMPLES OF INHIBITORS
Active Transport of Iodide Complex anions: Perchlorate, fluoborate, pertechnetate,
thiocyanate
Iodination of thyroglobulin Thionamides: Propylthiouracil, methimazole, carbimazole.
Thiocyanate, Aniline derivatives, Sulphonamides, Iodide.
Coupling reaction Thionamides, Sulphonamides,
Hormone release Lithium salts, Iodide
Iodotyrosine deiodination Nitrotyrosines
Peripheral iodothyronine
deiodination
Oral cholecystographic agents
Thiouracil derivatives, Amiodarone
Hormone excretion/
inactivation
Inducers of Hepatic drug metabolizing enzymes:
Phenobarbital, rifampin, carbamazepine, phenytoin
Hormone Action Thyroxine analogs, Amiodarone, Phenytoin,
Binding in gut: Cholestyramine.
Editor's Notes
Follicles: the Functional Units of the Thyroid Gland.
The follicles are the functional, secretory units of the thyroid gland.1 Follicular cells produce thick, proteinaceous colloid1,2 that fills the lumen.2,3 Colloid is composed primarily of thyroglobulin (Tg).4 Thyroglobulin is a high-molecular weight glycoprotein that facilitates the assembly of thyroid hormones within the thyroid follicular lumen.1 The amino acid tyrosine, which is incorporated within the molecular structure of Tg,1 becomes iodinated.2 Iodine is bound to tyrosyl residues in Tg at the apical surface of the follicle cells to form, in turn, monoiodotyrosine (MIT) and diiodotyrosine (DIT).1 MIT and DIT combine to form the 2 biologically active thyroid hormones, thyroxine (T4) and triiodothyronine (T3).1 In addition to providing the matrix for thyroid hormone synthesis,5 the Tg molecule also stores a large supply of iodine and thyroid hormone for secretion at a steady rate or on demand.5
References
Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000:488.
Fauci AS, et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:2012.
3. DeGroot LJ, Larson PR, Hennemann G: The Thyroid and Its Diseases. Chapter 1: Phylogeny, ontogeny, anatomy, and metabolic regulation of the thyroid, revised 01 August 2002 by Dumont JE, Corvilain B, and Maenhaut C. (Presented online at http://www.thyroidmanager.org). Accessed June 6, 2003.
4. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. McGraw Hill, New York; 1996:1385
5. Medeiros-Neto G, et al. Endocr Rev. 1993;14:165-183.
Iodine Sources.
Because of the scarcity and uneven distribution of iodine in the environment, the structure of the thyroid gland is adapted to collect and store this element in order to provide a continuous supply of thyroid hormone throughout life.1 The iodine ingested with the diet is the only source for this critical component of the thyroid hormones, but thyroid function largely depends on an adequate supply of iodine to the thyroid gland.2 Iodine is a trace element present in the human body in very small amounts (15 to 20 mg).2 The only role iodine has in the body is in the synthesis of thyroid hormones. If severe enough, iodine deficiency will impair thyroid hormonogenesis.2 The recommended daily dietary allowance (intake) of iodine for children and adults (except pregnant or lactating women) is 150 g.3
References
1. Nilsson M. Biofactors. 1999;10(2-3):277-85.
2. Braverman LE, Utiger RD, eds. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000:52, 295.
3. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1549.
Iodine Sources.
Because of the scarcity and uneven distribution of iodine in the environment, the structure of the thyroid gland is adapted to collect and store this element in order to provide a continuous supply of thyroid hormone throughout life.1 The iodine ingested with the diet is the only source for this critical component of the thyroid hormones, but thyroid function largely depends on an adequate supply of iodine to the thyroid gland.2 Iodine is a trace element present in the human body in very small amounts (15 to 20 mg).2 The only role iodine has in the body is in the synthesis of thyroid hormones. If severe enough, iodine deficiency will impair thyroid hormonogenesis.2 The recommended daily dietary allowance (intake) of iodine for children and adults (except pregnant or lactating women) is 150 g.3
References
1. Nilsson M. Biofactors. 1999;10(2-3):277-85.
2. Braverman LE, Utiger RD, eds. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000:52, 295.
3. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1549.
Biosynthesis of T4 and T3.
The major steps in the synthesis, storage, and release of thyroid hormones are: ingestion of iodine with the diet; active transport and uptake of iodide ion (I-) by the thyroid gland; the oxidation of iodide and the iodination of tyrosyl groups of thyroglobulin (Tg); coupling of iodotyrosine residues monoiodotyrosine (MIT) and diiodotyrosine (DIT) to generate iodothyronines; storage of iodinated Tg containing MIT, DIT, T4 and T3; and the proteolysis of Tg and the release of T4 and T 3 into the blood.1,2
References
Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1385.
2. Medeiros-Neto G, et al. Endocr Rev. 1993;14:165-183.
Biosynthesis of T4 and T3.
The major steps in the synthesis, storage, and release of thyroid hormones are: ingestion of iodine with the diet; active transport and uptake of iodide ion (I-) by the thyroid gland; the oxidation of iodide and the iodination of tyrosyl groups of thyroglobulin (Tg); coupling of iodotyrosine residues monoiodotyrosine (MIT) and diiodotyrosine (DIT) to generate iodothyronines; storage of iodinated Tg containing MIT, DIT, T4 and T3; and the proteolysis of Tg and the release of T4 and T 3 into the blood.1,2
References
Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1385.
2. Medeiros-Neto G, et al. Endocr Rev. 1993;14:165-183.
Biosynthesis of T4 and T3.
The major steps in the synthesis, storage, and release of thyroid hormones are: ingestion of iodine with the diet; active transport and uptake of iodide ion (I-) by the thyroid gland; the oxidation of iodide and the iodination of tyrosyl groups of thyroglobulin (Tg); coupling of iodotyrosine residues monoiodotyrosine (MIT) and diiodotyrosine (DIT) to generate iodothyronines; storage of iodinated Tg containing MIT, DIT, T4 and T3; and the proteolysis of Tg and the release of T4 and T 3 into the blood.1,2
References
Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1385.
2. Medeiros-Neto G, et al. Endocr Rev. 1993;14:165-183.
Biosynthesis of T4 and T3.
The major steps in the synthesis, storage, and release of thyroid hormones are: ingestion of iodine with the diet; active transport and uptake of iodide ion (I-) by the thyroid gland; the oxidation of iodide and the iodination of tyrosyl groups of thyroglobulin (Tg); coupling of iodotyrosine residues monoiodotyrosine (MIT) and diiodotyrosine (DIT) to generate iodothyronines; storage of iodinated Tg containing MIT, DIT, T4 and T3; and the proteolysis of Tg and the release of T4 and T 3 into the blood.1,2
References
Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1385.
2. Medeiros-Neto G, et al. Endocr Rev. 1993;14:165-183.
Biosynthesis of T4 and T3.
The major steps in the synthesis, storage, and release of thyroid hormones are: ingestion of iodine with the diet; active transport and uptake of iodide ion (I-) by the thyroid gland; the oxidation of iodide and the iodination of tyrosyl groups of thyroglobulin (Tg); coupling of iodotyrosine residues monoiodotyrosine (MIT) and diiodotyrosine (DIT) to generate iodothyronines; storage of iodinated Tg containing MIT, DIT, T4 and T3; and the proteolysis of Tg and the release of T4 and T 3 into the blood.1,2
References
Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1385.
2. Medeiros-Neto G, et al. Endocr Rev. 1993;14:165-183.
Active Transport and I- Uptake by the Thyroid.
Iodine ingested in the diet reaches the circulation in the form of the iodide anion (I-).1 Under normal circumstances, the concentration of iodine in the blood is very low (0.2 to 0.4 g/dL).1 Despite low concentrations of iodine in the blood following ingestion in the diet, the thyroid efficiently transports the iodide ion to the sites of hormone synthesis.1 The thyroid gland concentrates I- by a factor of 20 to 40 with respect to the concentration of the anion in the plasma under physiological conditions.2,3 Thus, I- accumulation in the thyroid is an active transport process that takes place against the I- electrochemical gradient, and is stimulated by TSH.1,2
References
1. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1385.
2. Dohan O, et al. Trends Endocrinol. Metab. 2000;11:99-105.
3. De La Vieja, et al. Physiol Rev. 2000;80:1083-105.
Proteolysis of Tg With Release of T4 and T 3.
The iodinated Tg, which contains MIT, DIT, T4, and T3, is stored in the colloid within the lumen of thyroid follicle cells.1 Proteolysis is necessary2 to release the synthesized thyroid hormones from peptide linkage within Tg.3 Proteolysis is initiated by endocytosis of colloid, which contains a high concentration of Tg3 from the follicular lumen at the cell apical surface.2 It is believed that in order for the thyroid hormones to be released, Tg must be broken down into its constituent amino acids.2 Tg forms intracellular colloid droplets that fuse with lysosomes containing proteolytic enzymes, including endopeptidases that split Tg to yield hormone-containing intermediates, and exopeptidases that act on the intermediates to release the thyroid hormones.2
The newly released hormones rapidly exit the cell at the basal membrane2 and enter the circulation.3 MIT and DIT are also released by hydrolysis of Tg, but they usually do not leave the thyroid, and instead are selectively metabolized.3 Iodothyronine-specific deiodinases can remove I- from MIT and DIT3 for reincorporation into protein2 for hormone synthesis.3 The remainder reenters the circulation.2
References
1. Yen PM. Physiol Rev. 2001;81:1097-1142.
2. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1387.
3. Braverman LE, Utiger RD, eds. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000:97-98.
Production of T4 and T3.
The thyroid gland is the sole source of endogenous T4, while only about 20% of T3 is produced in the thyroid.1 T4 is the most abundant iodothyronine in Tg and is about 10-20 times more abundant than T3.2 The thyroid secretes T4 and T3 in a proportion determined by the T4/T3 ratio in thyroglobulin (Tg), which is 15:1 in humans with minimal thyroidal conversion of T4 to T3.3 Normally, the ratio of secreted T4 to T3 is about 11:1.3 The serum concentrations and daily production rates of T4 are higher than those of any other iodothyronine.2 The estimated range of normal daily production of T4 is 70-90 g; for T3 the estimated range is about 15-30 g.4 Normal circulating concentrations of T4 in plasma range from 4.5-11.0 g/dL, while those for T3 are 100-fold less (60-180 ng/dL).4 One third to one half of the T4 that is secreted is converted to T3.2 The production of T4 and its extrathyroidal conversion to T3 provide a more constant source of T3 than were T3 to be solely produced by the thyroid.2 T3 is produced by 2 different and relatively independent processes about 20% via direct thyroid secretion and about 80% by extrathyroidal 5' deiodination of T4.4,5
References
1. Fauci AS et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:2013.
2. Braverman LE, Utiger RD, eds. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000:122.
3. Bianco AC, et al. Endocr Rev. 2002;23:38-89.
4. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1387-1388.
5. Hennemann G, et al. Endocr Rev. 2001;22:451-476.
Sites of T4 Conversion.
The major site of extrathyroidal conversion of T4 to T3 is the liver.1 In humans, D1, which is found in the liver, kidney, thyroid,1,2 and pituitary,2 generates circulating T3 for use by most peripheral target tissues.1 D2 was thought to be limited to the brain and pituitary,1 but has been found to be present in the human thyroid, heart, brain, spinal cord, skeletal muscle, and placenta.2 The distribution of D3 is mainly in the central nervous system, skin, and placenta.1,3
References
1. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1387-1388.
2. Bianco AC, et al. Endocr Rev. 2002;23:38-89.
3. Braverman LE, Utiger RD, eds. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000:125.
T4 Disposition.
In healthy individuals, about 41% of T4 is converted to T3, about 38% is converted to reverse T3 (rT3), and about 21% is metabolized via other pathways, such as conjugation in the liver and excretion in the bile. Reverse T3, which is metabolically inactive, results from removal of the iodine on position 5 of the inner ring. The normal circulating concentration of T4 is 4.5-11 g/dL. The normal circulation concentration of T3 is about 100-fold less (60-180 ng/dL).1
Reference
1. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1388.
Carriers for Circulating Thyroid Hormones.
Thyroid hormones are transported in the blood by carrier plasma proteins,1 which bind more than 99% of serum T4 and T3.2 Together, the carrier proteins keep the concentration of thyroid hormone constant over a wide range and provide a means for equal distribution of hormone among the tissues.2 Thyroxine-binding globulin (TBG) is the major carrier of thyroid hormones in the circulation because of its extremely high binding affinity, even though it represents only a small fraction of the total serum proteins.2 TBG binds 75% of T4,2 and has 10-20 times greater affinity for T4 than T3.2-4 Transthyretin (TTR) binds T4, but does not significantly bind T3.4 In spite of its low binding affinity, albumin carries about 7% of T4 because of its high serum concentration.2 The thyroid hormones also bind to plasma lipoproteins, with high-density lipoproteins (HDL) being the major binders.3 HDL transports about 3% of T4 and about 6% of T3 in serum.3 The transport proteins are affected by physiological changes, pharmacologic agents, and disease.3
References
1. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1388-1389.
2. Janssen OE, et al. J Clin Endocrinol Metab. 2002;87:1217-1222.
3. Braverman LE, Utiger RD, eds. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000:108-110,115.
4. Fauci AS, et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:2014.
Free Hormone Concept.
An early version of the free hormone concept (or hypothesis) stated that the free or diffusible thyroid hormone concentration in blood and extracellular tissues would determine the rate at which thyroid hormone was distributed to its point of action and the rates at which it was degraded and excreted.1 This concept, however, was shown to be only partly correct.1 The hypothesis was later modified to state that unbound serum concentrations of T4 and T3 are directly related to the amount of hormone entering the cells and to the cells’ ultimate physiologic response.2 In an equilibrium mixture containing hormone and several carrier proteins, the amount of hormone bound to a minor transport protein, such as LDL, will be proportional to the free hormone concentration.2 Only thyroid hormones in the free, unbound state are biologically active (0.03% and 0.3% of the total serum T4 and T3, respectively)3,4 and available to tissues.5 The metabolic state correlates more closely with the concentration of free hormone than total hormone in the circulation. Therefore, homeostatic regulation of thyroid function (the role of the HPT axis)6 is designed to maintain a normal concentration of free hormone.5
References
Henneman G, et al. Endocr Rev. 2001;22:451-476
2. Braverman LE, Utiger RD, eds. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000:115.
3. Janssen OE, et al. J Clin Endocrinol Metab. 2002;87:1217-1222.
4. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1389.
5. Fauci AS et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:2013.
6. Schussler GC. Thyroid. 2000;10:141-149.
Changes in TBG Concentration Determine Binding and Influence T4 and T3 Levels.
Because of the high degree of binding of thyroid hormones to serum carrier proteins, such as TBG, quantitative or qualitative changes in either the concentrations of the proteins or molecular changes in the binding affinity of the hormones for the protein have significant effects on the total serum hormone levels.1 Increased concentrations of TBG cause T4 and T3 levels to increase, while FT4 and FT3 remain unchanged. When TBG levels are decreased, T4 and T3 decrease and FT4 and FT3 concentrations remain unchanged.
For example, the alterations in total thyroid hormone levels in pregnancy are the direct result of the marked increase in serum TBG.2 Total T4 and T3 levels increase significantly during the first half of gestation, while there is a transient drop in FT4.2,3
References
Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1389.
2. Glinoer, D. Endocr Rev. 1997;18:404-433.
3. Muller AF, et al. J Clin Endocrinol Metab. 2000;85:545-548.
Drugs and Conditions That Increase Serum T4 and T3 Levels by Increasing TBG.
Only the unbound thyroid hormone has metabolic activity. Because of the high degree of binding of thyroid hormones to plasma proteins, changes in the protein concentrations or the binding affinity of the hormones for the proteins can greatly affect total serum hormone levels.
Certain drugs and physiologic conditions increase the binding of thyroid hormones to TBG. These drugs include estrogens, methadone, clofibrate, 5-fluorouracil, heroin, and tamoxifen. Conditions that increase the binding of thyroid hormones to TBG include liver disease, porphyria, HIV infection, and predisposed genetic determinants.1
Reference
1. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1389.
Drugs and Conditions That Decrease Serum T4 and T3 by Decreasing TBG Levels or Binding of Hormone to TBG.
Glucocorticoids, androgens, L-asparaginase, salicylates, mefenamic acid, antiepileptic drugs, and furosemide decrease the binding of thyroid hormones to TBG. Acute and chronic illness and predisposed genetic determinants also decrease binding.
Because the pituitary responds to and regulates circulating free hormone levels, minimal changes in free hormone concentrations are seen. Therefore, laboratory tests that measure only total hormone levels may be subject to misinterpretation.1
Reference
1. Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw Hill; 1996:1389.
Hypothalamic-Pituitary-Thyroid Axis Negative Feedback Mechanism.
In this negative-feedback system, increasing levels of circulating thyroid hormone inhibit the synthesis of TSH directly at the pituitary level and indirectly at the level of the hypothalamus by reducing the secretion of TRH.1,2 TRH is the major regulator of the synthesis and secretion of TSH, and therefore it plays a central role in regulating the hypothalamic-pituitary-thyroid (HPT) axis.3
Thyroid hormone can negatively regulate TSH transcription by direct and indirect mechanisms, and can negatively regulate TRH at the transcriptional level,1,4 decreasing transcription of TSH mRNA.4
References
Braverman LE, Utiger RD, eds. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000:206-207.
2. Dahl GE, et al. Endocrinology. 1994;135:2392-2397.
3. Nillni EA, et al. Endocr Rev. 1999;20:599-648.
4. Yen PM. Physiol Rev. 2001;81:1097-1142.